XOMA Royalty
Highly Engaged Employees
Highly Engaged EmployeesHolding Companies & Conglomerates · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2200 Powell St Ste 310, Emeryville, Cali...Phone Number
(510) 204-7200Website
www.xoma.comRevenue
$11.7 MillionStock Symbol
XOMAIndustry
ZI Rank: 11
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
9
2
5
6
11
About XOMA Royalty
XOMA Royalty, founded in 1981, is a research and development company specializing in biotechnology and pharmaceutical services. The company builds and manages a portfolio of products licensed to biotech and pharmaceutical companies for development. XOMA's business model functions as a royalty-aggregator, acquiring milestone and royalty rights associated with drug development programs that have third-party funding. The company focuses on antibody therapeutics across various therapeutic areas, with partner-funded programs spanning multiple stages of the drug development process. XOMA Royalty operates primarily in North America and Asia, providing both business-to-business and business-to-consumer services in the healthcare and biotechnology sectors.Explore more
XOMA Royalty Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is XOMA Royalty your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at XOMA Royalty
Earning: See what the market has to say on XOMA Royalty recently announced quarterly report
Check out if XOMA Royalty is spiking on competitors!
Check if XOMA Royalty has recently received funding, and reach out quickly before it becomes old news!
XOMA Royalty, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when XOMA Royalty launches new products
Click to see if XOMA Royalty had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once XOMA Royalty has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to XOMA Royalty
Compare insights from companies similar to XOMA Royalty, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$7M
11-50
Private
-
1995
LK
Leo KriksunovDirector, Marketing, Business Development & Intellectual Property
Company Profile Activity
Activity Insights
XOMA Royalty is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.
What does this means?
XOMA Royalty is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about XOMA Royalty.
XOMA Royalty Tech Stack
A closer look at the technologies used by XOMA Royalty
See more technologies
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Earnings
reported G&A expenses of $36 million for full year 2025, a small increase compared with $34.5 million in 2024. G&A included non-cash stock-based compensation expense of $9.3 million and $10.3 million in 2025 and 2024, respectively.
Earnings, Finance
Earnings
reported full-year total GAAP income and revenue of $52.1 million for 2025, compared with $28.5 million in 2024, representing significant growth in its top line.
Earnings, Finance
Pain Point
Pharmaceuticals, Clinical Operations
XOMA Royalty News & Media
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and ... - aktiencheck.de
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date () | aktiencheck.deXOMA Royalty Corporation Declares Quarterly Preferred Stock - GlobeNewswire
EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced that its Board of...XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date
EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced that its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s (i) 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) (the “Series A Preferred Stock”) (984,000 shares outstanding, CUSIP No. 98419J305) and (ii) depositary shares representing its 8.375% Series B Cumulative Perpetual Preferred Stock (Nasdaq: X
Read more news
Top Holding Companies & Conglomerates Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding XOMA Royalty
Sign Up For FreeTo access detailed company insights
XOMA Royalty, founded in 1981, is a research and development company specializing in biotechnology and pharmaceutical services. The company builds and manages a portfolio of products licensed to biotech and pharmaceutical companies for development. XOMA's business model functions as a royalty-aggregator, acquiring milestone and royalty rights assoc... Read More
